• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Insulet, Calm partner on emotional well-being resources for diabetes

July 14, 2026 By Sean Whooley

Calm Insulet GraphicInsulet (Nasdaq:PODD) announced today that it has partnered with Calm, a leading consumer mental health company.

The companies say they are coming together to provide emotional well-being resources for people living with diabetes, their caregivers, and healthcare professionals.

Acton, Massachusetts-based Insulet said the collaboration marks Calm’s first integrated content partnership and collection with a medtech company. It introduces bespoke mindfulness content called The Mind in Range Collection. The collection features short meditations, a breathing exercise, and a new Calm Sleep Story. Calm and Insulet designed these offerings specifically for the diabetes community.

Beginning today, Calm now offers a suite of free-to-access mindfulness tools created for the diabetes community. This includes a Sleep Story narrated by fashion model Lila Moss, a user of Insulet’s Omnipod who lives with type 1 diabetes. It also features guided meditations and a breathing exercise.

Insulet says this initiative targets people with diabetes who need more holistic care as mental health remains overlooked. It said studies show that mindfulness-based stress reduction can meaningfully reduce stress for people with diabetes over time.

This marks the latest collaboration for Insulet to bring diabetes awareness and resources to more people. The company introduced Dyasonic, a comic book hero with type 1 diabetes, last year. It also introduced “Omnipod Bay” into the video game “Animal Crossing” through a new feature announced four years ago.

Most recently, Insulet showcased Omnipod through the television series “Scrubs.” Read more about these promotional efforts in a recent interview with Senior Director, U.S. Consumer Marketing, Lucas Escobar.

Insulet said it plans to roll out the new Calm initiative with bespoke content throughout the year.

Commentary from Insulet and Calm leadership

Manoj Raghunandanan, Insulet chief growth officer, said:

“The unmet needs and daily realities of people living with diabetes shape how we innovate and who we choose to partner with. Living with this condition requires constant decisions, and over time that responsibility can create real stress and anxiety. Global data suggest that nearly 80% of people living with diabetes suffer burnout from the emotional strain and demands of daily management. We hold ourselves to a clear standard: do more for people while asking less of them. Partnering with Calm recognizes the emotional dimension of diabetes and expands the support we provide beyond physical outcomes.”

Dr. Chris Mosunic, Calm chief clinical officer, said:

“Mindfulness can play a powerful role in improving quality of life for people living with diabetes. By combining Calm’s expertise in this area with Insulet’s leadership in diabetes technology, we’re delivering tools and support that reduce cognitive burden and relieve emotional stress to improve mental wellness.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Insulet

IN CASE YOU MISSED IT

  • Insulet’s Omnipod Discover data platform begins full US rollout
  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS